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Abstract
The ppGpp molecule is part of a highly conserved regulatory system for mediating the growth response to various
environmental conditions. This mechanism may represent a common strategy whereby pathogens such as Yersinia pestis,
the causative agent of plague, regulate the virulence gene programs required for invasion, survival and persistence within
host cells to match the capacity for growth. The products of the relA and spoT genes carry out ppGpp synthesis. To
investigate the role of ppGpp on growth, protein synthesis, gene expression and virulence, we constructed a DrelA DspoT Y.
pestis mutant. The mutant was no longer able to synthesize ppGpp in response to amino acid or carbon starvation, as
expected. We also found that it exhibited several novel phenotypes, including a reduced growth rate and autoaggregation
at 26uC. In addition, there was a reduction in the level of secretion of key virulence proteins and the mutant was.1,000-fold
less virulent than its wild-type parent strain. Mice vaccinated subcutaneously (s.c.) with 2.5610
4 CFU of the DrelA DspoT
mutant developed high anti-Y. pestis serum IgG titers, were completely protected against s.c. challenge with 1.5610
5 CFU of
virulent Y. pestis and partially protected (60% survival) against pulmonary challenge with 2.0610
4 CFU of virulent Y. pestis.
Our results indicate that ppGpp represents an important virulence determinant in Y. pestis and the DrelA DspoT mutant
strain is a promising vaccine candidate to provide protection against plague.
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Introduction
Plague remains one of the most feared infectious diseases in
humans. The etiological agent of the disease, Yersinia pestis,i s
disseminated by fleas and infects both humans and rodents. Y. pestis
rapidly invades from the infection site into the lymphatic system and
circulation, to produce the systemic and often fatal disease [1].
Globally about 2000 cases of plague are reported to the World
Health Organization each year [2]. Most of these cases are the
bubonic form of the disease, usually a consequence of the
transmission of bacteria to humans via bites from fleas that have
previously fed on infected rodents although contact with domestic
cats that have been exposed to Y. pestis is another important
transmission mode because of the higher than average incidence of
pneumonic plague that occurs in these cases [1]. More rarely, cases
of pneumonic plague are reported that are characterized by a short
incubation period of 2 to 3 days and a high rate of mortality, even if
treated. Pneumonic plague can be transmitted person to person or
animal to person via the inhalation of contaminated air droplets [1].
Pneumonic plague is the most likely form to be encountered if Y.
pestis is used as a biological weapon [3].
Y. pestis overwhelms its mammalian host during systemic growth
by evading phagocytosis and by inhibiting the inflammatory
response [4]. These properties are associated with a 70-kb plasmid,
termed pCD1, which codes for a virulence-associated type III
secretion system (T3SS) [5]. The analogous 70-kb pYV (Yersinia
virulence) plasmid is found in Yersinia pseudotuberculosis and Yersinia
enterocolitica which primarily cause gastrointestinal disease. In
addition, Y. pestis has two plasmids that are absent in other
yersiniae: the 100-kb plasmid pMT1 proposed to contribute to the
survival of the bacteria in the flea [6], and the 9.5-kb plasmid
pPCP1, which is responsible for the invasive character of plague in
the mammalian host [7]. After subcutaneous (s.c.) administration
of Y. pestis in mice, the pPCP1 plasmid potentiates the spread of
bacteria into the circulation [7]. It was recently demonstrated that
pPCP1 also enhances invasion of Y. pestis into human epithelial
cells [8].
The stringent response is a generalized adaptive response to
nutritional deprivation and environmental stress. The production
of a specific nucleotide, guanosine-59,39-(bis)pyrophosphate
(ppGpp), is the primary signaling and initiating event in the
stringent response. In Escherichia coli and Salmonella enterica serovar
Typhimurium, the relA gene encodes an enzyme with guanosine
39,59 bis(diphosphate) synthetase activity, which carries out ppGpp
synthesis in response to a nutritional imbalance caused by amino
acid starvation leading to increased synthesis of ppGpp and a
reduction in stable RNA synthesis. This response to amino acid
limitation is absent in DrelA strains [9]. Basal levels of ppGpp
synthesized in the absence of relA activity during balanced growth
is regulated by spoT, which encodes an enzyme with both
guanosine 39,5 9-bis(diphosphate) 39-pyrophohydrolase and gua-
nosine 39,59 bis(diphosphate) synthetase activity [10]. The spoT
gene modulates ppGpp levels in response to a number of
nutritional factors including carbon starvation [10]. In Gram-
positive bacteria, a single RelA/SpoT protein is responsible for
both functions [11]. The relA and spoT genes play an important
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Mycobacterium tuberculosis [12], Listeria monocytogenes [13], Legionella
pneumophila [14,15], Vibrio cholerae [16], and Pseudomonas aeruginosa
[17]. A recent study indicated that a DrelA DspoT S. Typhimurium
is effectively noninvasive for epithelial cells in vitro and is attenuated
in BALB/c mice [18,19]. These genes were shown to play a
crucial role in the regulation of genes in Salmonella pathogenicity
islands 1 and 2 (SPI1, SPI2) and the spv virulence plasmid genes.
Taken together, these results suggest that ppGpp may play a
universal role in bacterial virulence gene expression.
The ppGpp molecule is part of a highly conserved regulatory
system for mediating the growth response to various environmen-
tal conditions. This mechanism may represent a common strategy
whereby facultative intracellular pathogens regulate the virulence
gene programs required for invasion, survival and persistence
within host cells to match the capacity for growth. However, the
role of the ppGpp in Y. pestis physiology and virulence has not been
investigated.
The goal of our study was to determine what role relA and spoT
play in Y. pestis physiology and virulence by constructing DrelA and
DrelA DspoT mutants and characterizing them for both in vitro and
in vivo characteristics. We examined the effect of these mutations
on transcription and protein levels at 26uC (flea temperature) and
at 37uC (human temperature) and the effect on host colonization,
immune responses and virulence. We also evaluated the double
mutant for its capacity to induce protective immunity. Our results
showed that the relA spoT mutant was attenuated for virulence and
induced protective immunity by s.c. vaccination against bubonic
and pneumonic plague.
Materials and Methods
Bacterial strains, culture conditions and plasmids
All bacterial strains and plasmids used in this study are listed in
Table 1. All strains were stored at 270uC in phosphate-buffered
glycerol. Y. pestis cells were grown routinely at 28uC on Congo red
agar from glycerol stocks and then grown in heart infusion broth
(HIB) or on tryptose-blood agar base (TBA) [20]. The chemically
defined medium PMH2 was used routinely [21]. All E. coli strains
were grown routinely at 37uC in LB broth [22] or LB solidified
with 1.2% Bacto Agar (Difco).
Plasmid construction
All primers used in this paper are listed in Table S1. The
original source for the tightly regulated araC PBAD in pYA3700 was
E. coli K-12 strain x289 [23]. For construction of the PBAD spoT
insertion/deletion into lacZ, primer sets of LacZ1/LacZ2 and
LacZ3/LacZ4 were used for amplifying lacZ-U (upstream gene
sequence of lacZ), and lacZ-D (downstream gene sequence of lacZ)
fragment, respectively. The lacZ-U and lacZ-D fragments were
cloned into the SphI/PstI sites and SacI/EcoRI sites of pYA3700 to
form pYA4573. The spoT gene fragment was amplified using
SpoT-1 and SpoT-2 primers. The primer SpoT-1 containing the
new SD sequence is shown Table S1. The spoT fragment was
cloned into pYA4573 to construct pYA4574. Plasmid pYA4574
was digested with PstI, blunt ended with T4 DNA polymerase and
dephosphorylated with Shrimp Alkaline phosphatase (Promega).
The cat-sacB fragment was cut from pYA4373 using PstI and SacI
restriction endonucleases and blunted by T4 DNA polymerase.
Then, the cat-sacB fragment was ligated into PstI site of pYA4574
to form plasmid pYA4575.
To construct a spoT-3x-flag-kan fusion, a C-terminal spoT gene
fragment (510 bp) was amplified using SpoTC-1 and SpoTC-2
primers and cloned into HindIII and BamHI sites of pUC18 to
construct pYA4642. The spoU’ gene fragment (sequence down-
stream of spoT) and lacZ-D gene fragment (sequence downstream
of lacZ) were amplified from genomic DNA using SpoTD-1/
SpoTD-2 and LacZ3/LacZ4 primers, respectively. The spoU’ and
lacZ-D fragment were cloned into SacI and EcoRI sites of pYA4642
to form pYA4643 and pYA4644, respectively. Then the 36flag-kan
gene fragment amplified from pYA4045 was cloned into SacI and
BamHI sites of pYA4643 and pYA4644 to construct pYA4645 and
pYA4646.
To delete the pla gene from plasmid pPCP1, plasmids pYA4647,
pYA4648, and pYA4649 were constructed. The pla-U fragment
was amplified from total DNA of Y. pestis KIM6
+ using Pla1 and
Pla2 primers and cloned into the EcoRI and PstI sites of pUC18 to
form pYA4647. The pla-D fragment was amplified using Pla3 and
Pla4 primers. The pla-D fragment was cloned into pYA4647 to
construct pYA4648. The cat cassette (including Flp recombination
site) amplified using Cm1 and Cm2 primers was cloned into the
PstI site of pYA4648 to form pYA4649.
Construction of Y. pestis mutant strains
The construction of strains x10003 and x10004 using a two-step
recombination method was previously described [24]. Strain
x10019 was constructed from strain x10004 using similar
methods. Briefly, plasmid pKD46 was introduced into x10004
by electroporation. A linear lacZ-U-cat-sacB-TT araC PBAD spoT-
lacZ-D fragment was purified from plasmid pYA4575 by digestion
with EcoRI and SphI and transformed into x10004 (pKD46)
competent cells. Electroporants were isolated on TBA+Cm
(10 mg/ml) plates. Integration of the lacZ-U-cat-sacB-TT araC
PBAD spoT-lacZ-D fragment into the correct site of the chromo-
some was verified by PCR. Colonies with the correct PCR profile
were streaked onto TBA+ Cm (10 mg/ml)+5% Sucrose plates to
verify sucrose sensitivity and onto HIB Congo Red+Cm (10 mg/
ml) plates to confirm the presence of the pgm locus. To remove the
cat-sac cassette from the chromosome, electrocompetent cells were
prepared from a sucrose-sensitive isolate and electroporated with
approximately 1 mg of a linear DNA (lacZ-U-TT araC) cut from
pYA4574 using SphI and BamHI. Electroporants were selected on
TBA+5% sucrose plates incubated at 30uC. Colonies were tested
using PCR to validate that the cat-sacB cassette was eliminated.
Plasmid pKD46 was cured from a single colony isolate of a
sucrose-resistant, chloramphenicol-sensitive strain to yield x10019.
To construct strains expressing spoT tagged with the Flag
epitope [25], plasmid pKD46 was introduced into Y. pestis KIM6
+
and x10019. The resulting strains were electroporated with
,0.5 mgo fspoTC-36flag-kan-spoU’ and spoTC-36flag-kan-lacZ-D
cut from pYA4645 and pYA4646, respectively. Electroporants
were selected on TBA+Kan (20 mg/ml) plates at 37uC. The
resulting colonies were verified using PCR to confirm that the
36flag-kan fragment was correctly inserted into the chromosome.
Plasmid pKD46 was cured from single colony isolates of Y. pestis
KIM5
+ or x10019 derivatives to yield x10021 and x10022,
respectively.
To construct Pla
2 mutants, Y. pestis KIM6
+ (pKD46), x10003
(pKD46), x10004 (pKD46) and x10019 (pKD46) competent cells
were electroporated with ,0.5 mg of PCR amplified, gel purified
pla-U::cat:pla-D fragment obtained with primers Pla1 and Pla4
using plasmid pYA4649 as the template. Electroporants were
selected on TBA+Cm (10 mg/ml) plates and were subsequently
verified by PCR to confirm that pla was deleted. Plasmid pCP20
was introduced into the pla mutant strains and the Cm
R cassette
was removed by flip recombinase [26]. Plasmid pCP20 was cured
from resulting single colony isolates to yield x10023, x10024,
x10025 and x10026. Then, the pCD1Ap plasmid was transformed
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+, x10003, x10004, x10019, x10023, x10024,
x10025 and x10026, respectively to form Y. pestis KIM5
+,
x10003(pCD1Ap), x10004(pCD1Ap), x10019(pCD1Ap), x10023
(pCD1Ap), x10024(pCD1Ap), x10025(pCD1Ap) and x10026
(pCD1Ap) under BSL3 containment.
ppGpp assay
ppGpp was detected using a slight modification of previously
described procedures [27,28]. To starve cells for amino acids,
strains were grown overnight in HIB medium at 26uC. The cells
were then harvested and washed three times with PBS and
resuspended to an OD620 of 0.15 in 1 ml of modified PMH2
medium lacking L-phenylalanine [28]. The culture was shaken at
250 rpm at 26uC for approximately 5 h until the OD620 reached
0.25, whereupon, [
32P] H3PO4 was added to 100 mCi/ml. Cells
were incubated for an additional 1 h at 26uC. Following
incubation, an equal amount of chilled 90% formic acid was
added to the cell suspension. The ice-cold suspensions were then
Table 1. Bacterial strains and plasmids used in this study.
Strains Relevant genotype or Annotation Source or derivation
E.coli TOP10 F
2 mcrA D(mrr-hsdRMS-mcrBC) w80lacZDM15 DlacX74 recA1 araD139 D (ara-leu)7697 galU galK rpsL endA1 nupG Invitrogen
Y. pestis KIM6
+ Pgm
+, pMT1, pPCP1, cured of pCD1 [21]
Y. pestis KIM5
+ Y. pestis KIM6
+ pCD1Ap [21]
x10003 DrelA233 Y. pestis KIM6
+ [24]
x10004 DrelA233 DspoT85 Y. pestis KIM6
+ [24]
x10019 DrelA233 DspoT85 DlacZ516::TT araC PBAD spoT Y. pestis KIM6
+ This study
x10021 spoT412:: 36Flag-Kan Y. pestis KIM6
+ This study
x10022 DrelA233 DspoT85 DlacZVTT araC PBAD spoT413:: 36Flag-Kan Y. pestis KIM6
+ This study
x10023 Dpla-525 Y. pestis KIM6
+ This study
x10024 DrelA233 Dpla-525 Y. pestis KIM6
+ This study
x10025 DrelA233 DspoT85 Dpla-525 Y. pestis KIM6
+ This study
x10026 DrelA233 DspoT85 Dpla-525 DlacZ516::TT araC PBAD spoT Y. pestis KIM6
+ This study
x10003(pCD1Ap) DrelA233 Y. pestis KIM6
+ pCD1Ap This study
x10004(pCD1Ap) DrelA233 DspoT85 Y. pestis KIM6
+ pCD1Ap This study
x10019(pCD1Ap) DrelA233 DspoT85 DlacZ::TT araC PBAD spoT Y. pestis KIM6
+ pCD1Ap This study
x10023(pCD1Ap) Dpla-525 Y. pestis KIM6
+ pCD1Ap This study
x10024(pCD1Ap) DrelA233 Dpla-525 Y. pestis KIM6
+ pCD1Ap This study
x10025(pCD1Ap) DrelA233 DspoT85 Dpla-525 Y. pestis KIM6
+ pCD1Ap This study
x10026(pCD1Ap) DrelA233 DspoT85 Dpla-525 DlacZ516::TT araC PBAD spoT Y. pestis KIM6
+ pCD1Ap This study
Plasmids Source
pUC18 For cloning and sequencing Invitrogen





r, FLP recombinase expression [26]
pKD3 Ap
r Cm
r, cat cassette template [26]
pKD46 Ap
r, l Red recombinase expression [26]




pYA4373 The cat-sacB cassette in the PstIa n dSacI sites of pUC18. pUC18
pYA4573 The lacZ-U (upstream gene sequence of lacZ), and lacZ-D (downstream gene sequence of lacZ) fragment were
cloned into the SphI/PstI sites and SacI/EcoRI sites of pYA3700 respectively.
pYA3700
pYA4574 The spoT gene with new SD sequence was cloned into the XhoI and SacI sites of pYA4573. pYA4573
pYA4575 The cat-sacB cassette from pYA4373 was ligated into PstI site of pYA4574. pYA4574
pYA4642 The C-terminal spoT gene fragment (510 bp) was cloned into HindIII and BamHI sites of pUC18. pUC18
pYA4643 The spoU’ gene fragment (downstream sequence of spoT) was cloned into SacIa n dEcoRI sites of pYA4642. pYA4642
pYA4644 The lacZ-D gene fragment (downstream sequence of lacZ) was cloned into SacIa n dEcoRI sites of pYA4642. pYA4642
pYA4645 The 36Flag::kan gene fragment was cloned into SacIa n dBamHI sites of pYA4643. pYA4643
pYA4646 The 36Flag::kan gene fragment was cloned into SacIa n dBamHI sites of pYA4644. pYA4644
pYA4647 The pla-U fragment (upstream sequence of pla) was cloned into the EcoRI and PstI sites of pUC18. pUC18
pYA4648 The pla-D fragment (downstream sequence of pla) was cloned into the SphIa n dPstI sites of pYA4647. pYA4647
pYA4649 The cat cassette (including Flp recombination site) was cloned into the PstI site of pYA4648. pYA4648
doi:10.1371/journal.pone.0006720.t001
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extracts were centrifuged in a minifuge set at the highest speed for
5 min, and 5 ml of supernatant was then applied to a
polyethyleneimine–cellulose thin-layer chromatography plate
(TLC). The TLC plates were developed at room temperature
with 1.5 M KH2PO4 (pH 3.4). The developed plates were then
air-dried and visualized by autoradiography using X-ray film at
270uC. To starve cells for carbon, strains were grown overnight in
HIB medium. For strain x10019, two cultures were grown, one
with and one without the addition of 0.05% arabinose. The cells
were harvested, washed three times using PBS and resuspended to
an OD620 of 0.15 in 1 ml of modified PMH2 medium without
glucose or arabinose. Cultures were grown, labeled and evaluated
by TLC as described above.
Analysis of virulence factor transcription by RT-PCR
Total RNA was extracted from bacterial cells using TRIzol
Reagent (Invitrogen) according to the manufacturer’s recommen-
dations. RNA samples were treated with DNase I for 10 min at
37uC to degrade contaminating DNA followed by inactivation of
DNase I with 2 mM EDTA and heating to 65uC for 10 min. RNA
was then precipitated with sodium acetate and ethanol and washed
with 70% ethanol prior to performing RT-PCR. RNA samples of
200 ng were used for reverse transcription, using random hexamer
primers and Superscript II reverse transcriptase as described by
the manufacturer (Invitrogen). PCR amplification was performed
using the lcrV yopB, yopD, yopE, yopH, yopJ, yopK, yopM, yopT or 16S
rRNA primer pairs listed in Supplementary Table S1. RNA
samples were used as templates in PCR reactions for RT minus
controls. Twenty cycles of amplification were performed using an
annealing temperature of 58uC. Products were then separated on a
1% agarose gel, stained with ethidium bromide and imaged for
visualization of appropriately sized PCR products. In all cases,
reactions were performed in triplicate.
Protein analysis
Secreted virulence factors were prepared by using a modifica-
tion of previously described methods [29]. Y. pestis was grown in
HIB medium overnight at 26uC. The cells were then harvested
and washed three times using PMH2, inoculated to 40 ml of fresh
PMH2 medium to an OD600 of 0.05 and shaken overnight at
26uC. Cultures were shifted to 37uC for 6 h with shaking to
provide mild aeration. Bacterial cells were removed by centrifu-
gation for RNA extraction. Secreted virulence factors from the
culture supernatants were concentrated by precipitation with 10%
(w/v) trichloroacetic acid overnight at 4uC. Precipitated proteins
were collected by centrifugation, washed with ice-cold acetone,
and dissolved in 0.05 M Tris-HCl buffer (pH 9.5). Insoluble
materials were removed by centrifugation at 12 500 g for 15 min
and the protein concentration in the supernatant was determined
using the DC protein assay kit (Bio-Rad Laboratories, Hercules,
CA). Samples containing 200 mg proteins were heated at 95uC for
5 min in protein sample buffer containing 2-mercaptoethanol and
analyzed by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) with 10% polyacrylamide. Proteins were
transferred to nitrocellulose membranes. The membranes were
blocked with 5% skim milk in PBS, incubated with rabbit
polyclonal antibodies specific for the indicated Yop proteins or
LcrV, and washed with PBS-Tween 20. Then alkaline phospha-
tase-conjugated goat anti-rabbit immunoglobulin G (IgG) (Sigma,
St. Louis, MO) was added in PBS-Milk. Immunoreactive bands
were detected by the addition of NBT/BCIP (Sigma, St. Louis,
MO). The reaction was stopped after 5 min by washing with
several large volumes of deionized water.
Two-dimensional gel electrophoresis
Comparison of two dimensional protein profiles was carried out
as previously described [30]. Y. pestis KIM5
+ and
x10004(pCD1Ap) were grown at 26uCo r3 7 uC in 5 ml of best-
case-scenario (BCS) medium without Ca
2+. The cultures were
harvested by centrifugation and washed once with low salt PBS
(0.16). Cells were resuspended in 1 ml lysis buffer containing 8M
Urea, 0.05M DTT, 2% (w/v) CHAPS and 0.2% (w/v)
ampholytes. Proteins were extracted by vortexing 1 ml cell
samples in lysis buffer with 0.2 mm glass beads ten times for
30 s with cooling between vortexing. The samples were centri-
fuged at 2500 g for 5 min to remove the beads. The bead-free
supernatant was centrifuged at 15000 g for 15 min at 4uCt o
remove cellular debris. The cell-free lysates were immediately
placed on ice and protease inhibitor was added. The lysates were
retreated with a 2D protein cleanup kit (Bio-Rad, Hercules, CA)
and protein concentration was determined using the Bio-Rad
Protein Assay kit.
Protein lysates (300 mg) were mixed with rehydration buffer
(Bio-Rad) in a total volume of 300 mL. Equal amounts (300 mg) of
protein were isoelectrically focused using 17 cm pH 4–7 strips
followed by 18.3619.3 cm 8–16% SDS–PAGE using Midi-
Protean II 2D cell (Bio-Rad). Gels were stained with Coomassie
Brilliant Blue R-250 (Bio-Rad) and visualized using Gel Doc XR
system (Bio-Rad). Protein expression levels from protein spots on
gels were compared between the different samples. Gel analysis
was performed using the PDQuest3 2-D Analysis Software (Bio-
Rad) to determine differential expression. Differentially expressed
protein spots were excised and were digested with In-Gel Tryptic
Digestion Kit (Pierce, Rockford, IL). Peptide digests were analyzed
using a Voyager DE STR MALDI-TOF mass spectrometer
(Applied Biosystems, Framingham, MA). Data were searched in
bacterial proteomics database using Aldente in ExPASy Proteo-
mics Server. This experiment was performed four times with
similar results.
Virulence studies in mice
Single colonies of each strain were used to inoculate HIB
cultures and grown overnight at 26uC. To select for plasmid
pCD1Ap, ampicillin was added into the medium at a concentra-
tion of 25 mg/ml. Bacteria were diluted into 10 ml of fresh HIB
enriched with 0.2% xylose and 2.5 mM CaCl2 to obtain an OD620
of 0.1 and incubated at 26uC for s.c. infections (bubonic plague) or
at 37uC for intranasal (i.n.) infections (pneumonic plague). Both
cultures were grown to an OD620 of 0.6. The cells were then
harvested and the pellet resuspended in 1 ml of isotonic PBS.
All animal procedures were approved by the Arizona State
University Animal Care and Use Committee. Female 7-week-old
Swiss Webster mice from Charles River Laboratories were
inoculated by s.c. injection with 100 ml of bacterial suspension.
Actual numbers of colony-forming units (CFU) inoculated were
determined by plating serial dilutions onto TBA agar. To
determine 50% lethal dose (LD50), five groups of six mice were
infected with serial dilutions of the bacterial suspension. For in
vivo complementation of strain of x10019(pCD1Ap), 120 mg of L-
arabinose dissolved in PBS was intraperitoneally administered to
mice on the day of inoculation and once a day thereafter [31].
Mice were monitored twice daily for 21 days, and the LD50 was
calculated as described [32].
For colonization/dissemination analysis, 3 mice per time point
were infected by s.c. injection in the front of the neck. At the
indicated times after infection, mice were euthanized, and samples
of blood, lungs, spleen and liver were removed. The bacterial load
for each organ was determined by plating dilutions of the
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as CFU per gram of tissue or CFU per ml blood. Infections were
repeated in at least two independent experiments.
Preparation of bacterial antigens
Bacterial antigens used for ELISA were prepared from fresh
cells. Briefly, single colonies of Y. pestis KIM5
+ were inoculated into
HIB media and cultured overnight at 26uC. Cells were switched to
37uC for 6 h. Bacterial cultures were centrifuged at 5,0006g for
10 min, the pellet was washed once with sterile PBS and
resuspended in sterile PBS. Bacterial cells were broken using
0.2 mm glass beads 10 times for 60 s with cooling between
vortexing (with 2 min incubation on ice between cycles). The
whole bacterial lysate was sterilized by UV light and sterility was
confirmed by TBA agar culture. The lysate was frozen at 280uC
until use. Protein content was determined by BCA analysis per
manufacturer’s instructions (Sigma).
Enzyme-linked Immunosorbent Assay (ELISA)
Mice were lightly anesthetized using ketamine and xylazine
mixture administered intramuscularly. Blood was collected by
retro-orbital sinus puncture for the determination of antibody
titers at different time points. ELISA was used to assay serum
antibodies against the whole cell lysate of Y. pestis KIM5
+. Sera
were tested for IgG at a starting dilution of 1:1000, and for IgG1
and IgG2a at 1:100, respectively.
Polystyrene 96-well flat-bottom microtiter plates (Dynatech
Laboratories Inc., Chantilly, VA) were coated with 200 ng/well of
Y. pestis whole cell lysates. Antigens suspended in sodium
carbonate-bicarbonate coating buffer (pH 9.6) were applied in
100 ml volumes to each well. The coated plates were incubated
overnight at 4uC. Free binding sites were blocked with a blocking
buffer (phosphate-buffered saline [PBS; pH 7.4], 0.1% Tween 20,
and 1% bovine serum albumin). A 100 ml volume of serially
diluted sample was added to individual wells in triplicate and
incubated for 1 h at 37uC. Plates were treated with biotinylated
goat anti-mouse IgG, IgG1, or IgG2a (Southern Biotechnology
Inc., Birmingham, AL). Wells were developed with streptavidin-
horseradish peroxidase conjugate (Invitrogen, Carlsbad, CA),
followed by 2,2-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid)
(ABTS) (Sigma) in sodium citrate buffer containing 0.03%
hydrogen peroxide (H2O2). After a 10 min incubation at 37uC
in the dark, color development (absorbance) was recorded at
405 nm using an automated ELISA plate reader (model
EL311SX; Biotek, Winooski, VT). Absorbance readings that were
0.1 higher than PBS control values were considered positive.
In vivo cytokine analysis
Cytokines were quantitated by a double-sandwich enzyme-
linked immunosorbent assay (ELISA) as described previously [33].
Mice in groups of three were euthanized at intervals by terminal
bleeding under anesthesia. Pooled blood was allowed to clot
overnight at 4uC, and serum was separated by centrifugation at
10,000 g for 10 min. Sera were filtered once through a 0.22 mm
syringe filter, cultured on TBA to confirm that bacteria had been
removed and stored at 270uC prior to assay for cytokines.
Commercial solid-phase enzyme immunoassays utilizing the
multiple-antibody sandwich principal were used to determine
cytokines in biological samples. In these experiments, IL-10, TNF-
a and IFN-c were determined with Mouse IL-10, IFN-c and
TNF-a Ready-SET-Go kits (ebioscience), respectively. Concen-
trations of cytokines were measured by reading optical density at
450 nm and then calculated in reference to values obtained in
standard curves generated for each assay. Assays of pooled sera
were repeated three times.
Protective efficacy
Two groups of Swiss Webster mice (10 mice/group) were
immunized by s.c. injection with 2.5610
4 CFU of
x10004(pCD1Ap) cells in 100 ml of isotopic PBS on day 0. Two
groups of mice (4 mice/group) were injected with 100 ml of PBS as
controls. On day 35, animals were challenged by s.c. injection with
100 ml of virulent Y. pestis KIM5
+ or lightly anesthetized with a 1:5
xylazine/ketamine mixture and challenged by the intranasal route
with 20 ml of bacterial suspension. The challenge dose for s.c.
injection was 1610
5 CFU and for i.n. challenge was 2.0610
4
CFU. Protective efficacy was determined by the number of
surviving animals. All infected animals were observed over a 15-
day period for the development of signs of plague infection.
Statistical analysis
Data are expressed as means6SE. One-way analysis of variance
with Student t-test were used for statistical analysis. A P-value
of,0.05 was considered significant.
Results
Sequence analysis of the relA and spoT genes
Analysis of the Y. pestis KIM5
+ database revealed the presence of
relA and spoT genes homologous to E. coli K-12 and S.
Typhimurium LT-2 [34,35,36]. The Y. pestis RelA protein shares
84.7% identity with E. coli K-12 and 83.9% identity with S.
Typhimurium LT-2 RelA proteins. The Y. pestis SpoT protein has
91.3% identity with E. coli K-12 and 91.8% identity with S.
Typhimurium LT-2 SpoT proteins.
Our analysis indicated that Y. pestis SpoT, but not RelA,
possesses the HD domain that is conserved in a superfamily of
metal-dependent phosphohydrolases [37]. Histidine (H) and
aspartate (D) residues in the HD domain are thought to be
involved in (p)ppGpp degradation [37]. Both Y. pestis RelA and
SpoT proteins possess the conserved ATP/GTP-binding and GTP
binding domains, TGS [38] and ACT [39,40], respectively, that
are present in the E. coli RelA and SpoT proteins [41]. The
presence of these conserved motifs in the Y. pestis proteins is in
agreement with their biochemical functions because ATP and
GTP are substrates of the reaction catalyzed by (p)ppGpp
synthetase.
The relA and spoT genes are involved in synthesis of
ppGpp and physiological differentiation
To evaluate the linkage between relA and spoT and the
production of ppGpp, we constructed DrelA, DrelA DspoT [24]
and DrelA DspoT DlacZ::TT araC PBAD spoT mutants of Y. pestis
KIM6
+ strain (Fig. 1). To construct a strain with arabinose-
regulated spoT expression, a TT araC PBAD promoter cassette was
inserted in front of the spoT gene. The spoT gene is located in the
middle of an operon. To avoid affecting the transcription of
nearby genes, the TT araC PBAD spoT construct was inserted at
another location, lacZ (Fig. 1).
Because of the high degree of similarity between Y. pestis RelA
and SpoT proteins and their E. coli and Salmonella counterparts, it
is likely that the function of RelA and SpoT in Y. pestis will be the
same. To evaluate the effect of relA and spoT on ppGpp synthesis
during amino acid starvation, Y. pestis was grown in PHM2 media
[21] without L-phenylalanine. ppGpp accumulation was observed
in wild-type Y. pestis, but not in the relA null strains (Figure 2A),
illustrating that Y. pestis is indeed capable of ppGpp biosynthesis in
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carbon starvation. When glucose was exhausted in the medium,
ppGpp accumulated in the wild type and DrelA spoT
+ strains, but
not in DrelA DspoT strains (Figure 2B). These results indicate that
Y. pestis has a RelA-dependent response to amino acid starvation
and a SpoT-dependent response to glucose starvation, comparable
to what is observed in E. coli [42]. The SpoT deficiency could be
complemented in strain x10019 (DrelA233 DspoT85 DlacZ516::TT
araC PBAD spoT) by the addition of arabinose. Synthesis of SpoT in
strain x10019 in the presence of 0.05% arabinose was nearly
identical to wild-type SpoT synthesis (Fig. S1 and S2). The
addition of arabinose to strain x10019 also restored ppGpp
synthesis when cells were starved for carbon (Fig. 2B).
A cursory examination of the Y. pestis DrelA DspoT double
mutant after growth on solid rich medium indicated that the DrelA
DspoT double mutants grew more slowly than wild-type or DrelA
mutants. When growth was assessed in liquid medium, the DrelA
DspoT mutants exhibited a longer lag phase and did not reach as
high a final OD600 than the wild-type and DrelA mutant strains at
both 26uC and 37uC (Fig. 3A and B). The DrelA DspoT strains were
prone to autoaggregate and precipitate to the bottom of the
culture tube at 26uC, but not at 37uC (data not shown). The
addition of 0.05% arabinose restored wild-type growth character-
istics to strain x10019 (DrelA233 DspoT85 DlacZ516::TT araC PBAD
spoT) (Fig. 3), but it continued to autoaggregate and precipitate at
26uC. However, the addition of higher concentrations of arabinose
reduced autoaggregation in a concentration-dependent manner.
The addition of 0.4% arabinose resulted in the complete absence
of detectable autoaggregation at 26uC.
The effect of ppGpp on production of virulence factors of
Y. pestis
The virulence of the pathogenic Yersinia species depends on a
plasmid-encoded type III secretion system (T3SS) that transfers
effector proteins called Yops (Yersinia outer proteins) into host cells,
interfering with mammalian cell signaling pathways, inhibiting
phagocytosis, modulating cytokine production, and inducing
apoptosis [43]. In S. Typhimurium, pathogenicity islands 1 and
2 (SPI1 and SPI2) encode T3SSs required for invasion and
replication within host cells, respectively [44]. SPI1 and SPI2 gene
transcription and expression are severely reduced in the absence of
ppGpp [45]. To determine if ppGpp had a similar effect on Y.
pestis, transcription of the genes encoding T3SS substrates LcrV
and Yop proteins was analyzed using RT-PCR. Our results
indicated that relA or relA spoT status did not have a significant
effect on the transcription of lcrV and or the yop genes (Fig. 4A).
To examine the effect of ppGpp on protein synthesis, the
proteome of wild-type and DrelA DspoT mutant Y. pestis strains was
compared at different temperatures using two-dimensional
electrophoresis (Fig. S3). Our results indicate that deletion of relA
and spoT led to reduced synthesis of some metabolic enzymes at
flea (26uC) and human (37uC) temperatures, and also reduced
synthesis of virulence factors such as Pla, LcrH and LcrV at 37uC
(Table 2 and Table 3).
We also evaluated secretion of LcrV and some of the Yops.
Recovery of secreted Yop proteins is hampered by degradation
due to Pla activity [46]. Therefore, secretion of virulence factors
was evaluated in Dpla derivatives, x10023(pCD1Ap) (Dpla),
x10024(pCD1Ap) (Dpla DrelA), x10025(pCD1Ap) (Dpla DrelA
DspoT) and x10026(pCD1Ap) (Dpla DrelA DspoT araC PBAD spoT).
The results indicate that LcrV and YopM secretion was reduced
slightly in absence of ppGpp (DrelA DspoT), but secretion of YopH,
YopD and YopE were significantly decreased (Fig. 4B).
A DrelA DspoT mutant is attenuated in mice
To investigate the contribution of ppGpp to the virulence of Y.
pestis, we infected groups of three Swiss Webster mice subcutane-
ously with wild-type, x10003(pCD1Ap) (DrelA233),
x10004(pCD1Ap) (DrelA233 DspoT85) and x10019(pCD1Ap)
(DrelA233 DspoT85 DlacZ516::TT araC PBAD spoT), in which spoT
expression is regulated by arabinose availability. Strain
x10019(pCD1Ap) was grown in the presence of arabinose prior
to inoculation of mice. Once this strain colonizes host tissues
where there is no free arabinose [23], it will become phenotyp-
ically SpoT
2. In preliminary experiments we determined that the
LD50 of the wild-type strain in mice is,10 CFU, consistent with
previous results [47,48]. Mice given wild-type Y. pestis KIM5
+ and
x10003(pCD1Ap) (DrelA) succumbed to the infection in a highly
synchronous manner (Fig. 5). Only 50% of the mice infected with
5.8610
5 CFU of DrelA DspoT strain x10004 developed plague after
6 days, and the rate at which the mice died was slower than the
rate of those infected with the wild-type strain. The LD50 of
Figure 1. Schematic chromosome structure of Y. pestis KIM6
+, x10003 (DrelA233), x10004 (DrelA233DspoT85) and x10019 (DrelA233
DspoT85 DlacZ::TT araC PBAD spoT).
doi:10.1371/journal.pone.0006720.g001
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5 CFU. Thus, the lack of ppGpp
resulted in a ,100,000-fold increase in the LD50 obtained
by subcutaneous (s.c.) infection. The LD50 of x10019(pCD1Ap)
strain, administered after growth in arabinose was intermediate, at
3.3610
2 CFU (,100-fold increase). The LD50 of x10019
(pCD1Ap) was the same as KIM5
+ (LD50,10) when inoculated
mice were injected with arabinose, indicating full complementa-
tion of the attenuation phenotype.
To further evaluate the ability of Y. pestis to disseminate to the
bloodstream and internal organs, we monitored the growth of both
Y. pestis KIM5
+ and x10004(pCD1Ap) in the lungs, spleens, livers
and blood of infected mice over a 7-day period after s.c. injection.
Because of the difference in LD50 between the two strains, we
inoculated mice with different doses of each, 1.5610
3 CFU of Y.
pestis KIM5
+ or 1.6610
6 CFU of x10004(pCD1Ap). The kinetics
of colonization was similar for both strains (Fig. 6). Despite the
difference in dose, the levels of bacteria in blood, spleen and liver
were similar for both strains on days 3 and 5. There was an
approximate 1.5 log difference in bacteria isolated from lung
tissue, indicating that the DrelA DspoT mutant had was less efficient
than KIM5
+ at reaching the lungs. By day 7, the number of the
DrelA DspoT mutant began to decline in all tissues, indicating
clearance by the host, while all of the mice inoculated with wild-
type Y. pestis had succumbed to the infection.
The immune responses to DrelA DspoT Y. pestis strain
x10004(pCD1Ap)
Because x10004 was attenuated, we explored its potential as a
vaccine. To evaluate the immune responses to DrelA DspoT Y. pestis
strain x10004(pCD1Ap), two groups of 10 mice each were
immunized s.c. with 2.5610
4 CFU on day 0. Two groups of 4
mice each were injected with PBS as controls. Mice were
challenged on day 35 with either 1.5610
5 (s.c.) or 2.0610
4 (i.n.)
Figure 2. Analysis of (p)ppGpp synthesis in Y. pestis KIM6
+ and DrelA DspoT mutants during amino acid and carbon starvation by
TLC. Total intracellular nucleotides were extracted from Y. pestis cultures uniformly labeled with [
32P] H3PO4. Cells were grown in modified PMH2
medium lacking L-phenylalanine for amino acid starvation (A) and in modified PMH2 medium without glucose for carbon starvation (B).
doi:10.1371/journal.pone.0006720.g002
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+. Blood was taken at 2 and 4 weeks post
immunization and 2 weeks after challenge. Serum IgG responses
to Y. pestis whole cell lysates (YpL) from immunized mice were
measured by ELISA (Fig. 7A). At two weeks after immunization,
the reciprocal anti-Y. pestis serum IgG titers were greater than
1,000 and increased at 4 weeks and after challenge.
The serum immune responses to YpL were further examined by
measuring the levels of IgG isotype subclasses IgG1 and IgG2a.
Th1 cells direct cell-mediated immunity and promote class
switching to IgG2a, and Th2 cells provide potent help for B-cell
antibody production and promote class switching to IgG1 [49].
The level of anti-YpL IgG1 and IgG2a isotype antibodies rapidly
increased after vaccination and gradually increased at 2 weeks, 4
weeks and post-challenge (Fig. 7B). At 2 and 4 weeks post-
immunization, the ratio of IgG1 to IgG2a was 1.06:1 and 1.2:1
respectively, indicating an initial mixed Th1/Th2 response, which
developed into a slight Th2 bias by week 4. This Th2 bias
continued after challenge as well.
Immunization with a DrelA DspoT Y. pestis strain
x10004(pCD1Ap) can protect against plague challenge
To evaluate the protective efficacy of DrelA DspoT Y. pestis strain
x10004(pCD1Ap) against the bubonic and pneumonic forms of
plague, immunized mice were challenged on day 35 with either
1.5610
5 (s.c.) or 2.0610
4 (i.n.) CFU of Y. pestis KIM5
+. Post-
challenge survival was monitored for 14 days. A single s.c.
vaccination could provide complete protection against s.c.
challenge without any symptoms (Fig. 8A) and 60% protection
against pulmonary challenge (Fig. 8B). None of the mice
immunized with PBS survived either challenge (Fig. 8).
Induction of cytokines by Y. pestis KIM5
+ and DrelA DspoT
strain x10004(pCD1Ap)
Cytokines are critical to the development and functioning of
both the innate and adaptive immune responses. They are often
secreted by immune cells that have encountered pathogens,
thereby activating and recruiting additional immune cells to
increase the system’s response to the pathogen. Previously, LcrV
has been demonstrated to be an immunomodulator (TNF-a and
IFN-c down-regulation and IL-10 induction) both in vivo and in
vitro [50,51,52]. Since the synthesis and secretion of LcrV is
reduced in the DrelA DspoT mutant, we compared production of
three cytokines (IL-10, INF-c and TNF-a) in mice infected with Y.
pestis KIM5
+ and x10004(pCD1Ap). For this experiment, groups
of three Swiss-Webster mice were inoculated via the s.c. route with
1.5610
3 CFU of Y. pestis KIM5
+ or 1.6610
6 CFU of
x10004(pCD1Ap). A group of uninfected mice served as controls.
Blood was collected via cardiac puncture 3 and 5 days later for
cytokine analysis. Measurements indicated that levels of IL-10
were higher in the sera of animals infected with Y. pestis KIM5
+
than that of x10004(pCD1Ap) (Fig. 9). The pro-inflammatory
cytokines IFN-c and TNF-a were not detected in sera from mice
inoculated with either strain (data not shown).
Discussion
The bacterial global signal molecule, ppGpp, plays a major role
in translating the nutritional state of bacteria into appropriate
expression of virulence genes. Our studies indicated that relA and
spoT deletion mutants of Y. pestis and S. Typhimurium have
similar, but not identical, effects on growth and virulence. A DrelA
deletion does not affect the growth of either Y. pestis (Fig. 3) or S.
Typhimurium (data not shown). In addition, as is the case for S.
Typhimurium, the Y. pestis DrelA DspoT mutants fail to reach the
same final cell density as their wild-type parents (Fig. 3) [18].
However, the DrelA DspoT Y. pestis strain showed a slight growth
defect in vitro, a phenomenon not reported for S. Typhimurium
[18].
The DrelA DspoT mutant was prone to autoaggregate and
precipitate at 26uC. This phenotype was not apparent at 37uC.
This phenomenon was never reported in DrelA DspoT mutants of
Salmonella and E. coli. However, we could find no published
experiments where the mutants had been grown at 26uCo ra
similar low temperature. To investigate whether this phenotype
could be observed in S. Typhimurium, we cultured wild type,
DrelA, and DrelA DspoT S. Typhimurium UK-1 at 26uC and 37uC.
We did not observe autoaggregation or precipitation at 26uC (data
not shown), indicating that this phenotype is specific for Y. pestis.I n
addition, autoaggregation was not alleviated in strain x10019
(DrelA DspoT araC PBAD spoT) by addition of 0.05% arabinose, a
concentration that allowed complementation of other phenotypes
relating to ppGpp formation (Fig. 2), growth (Fig. 3) and Yop and
LcrV secretion (Fig. 4B). Autoaggregation was, however, elimi-
nated by the addition of 0.4% arabinose, indicating that a higher
level of spoT expression was required to alleviate this phenotype.
Figure 3. Growth of Y. pestis strains in HIB medium at different temperatures (A) Growth curve at 26uC; (B) Growth curve at 37uC.N,
Y. pestis KIM5
+; &, x10003(pCD1Ap) (DrelA233) m, x10004(pCD1Ap) (DrelA233DspoT85); ., x10019(pCD1Ap) (DrelA233 DspoT85
DlacZ::TT araC PBAD spoT) without arabinose;¤ , x10019(pCD1Ap) (DrelA233 DspoT85 DlacZ::TT araC PBAD spoT) with 0.05% arabinose.
doi:10.1371/journal.pone.0006720.g003
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Protein
number Protein name Accession No. Function Method Fold change
WT/DrelADspoT
1 PanC (pantoate–beta-alanine ligase) y0785 biosynthesis of cofactors, carriers: pantothenate MALDI 7.3
2 hypothetical protein y2262 putative MALDI 15.2
3 S-ribosylhomocysteinase y0888 catalyzes the hydrolysis of S-ribosylhomocysteine
to homocysteine and autoinducer-2
MALDI 8.6
4 MetG (methionyl-tRNA synthetase) y2648 aminoacyl tRNA synthetases, tRNA modification MALDI 2.7
5 PyrE (orotate phosphoribosyltransferase) y0096 pyrimidine ribonucleotide biosynthesis MALDI 2.5
6 PyrB (aspartate carbamoyltransferase catalytic
Subunit)
y0161 pyrimidine ribonucleotide biosynthesis MALDI 3.6
doi:10.1371/journal.pone.0006720.t002
Figure 4. Analysis of virulence factor expression and secretion in Y. pestis KIM5
+ and mutants. (A) Evaluation of virulence factor
transcription by semi-quantitative RT-PCR. (B) Measurement of secreted virulence factors in culture supernatants by western blotting. Secreted
proteins were collected from the culture medium following the removal of bacterial cells. Proteins were separated by SDS-PAGE and detected by
western blotting. For each sample, the same amount of total protein was loaded.
doi:10.1371/journal.pone.0006720.g004
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virulence and pathogenesis of S. Typhimurium including SPI-1
and SPI-2 encoded genes essential for invasion and the spv operon,
involved in systemic infections [44,45]. In Y. pestis, the 70-kb
virulence plasmid, pCD1, encodes a complex virulence property
called the low-Ca
2+ response (LCR) [53,54]. The LCR was first
observed in vitro, where the bacteria respond to the absence of
Ca
2+ at 37uC by the strong expression and secretion of Yops and
LcrV [4]. This is accompanied by growth restriction, in which the
yersiniae undergo an orderly metabolic shutdown and cease
growth [55,56]. The phenomenon is phenotypically similar to the
stringent response which is induced by ppGpp synthesized when
cells encounter amino acid or carbon starvation [10]. However,
early research indicated that Y. pestis, although capable of ppGpp
biosynthesis, did not utilize this pathway to mediate its
temperature-dependent response to Ca
2+-deficient environments.
Early lesions in RNA synthesis associated with the growth
restriction of Ca
2+-deprived Y. pestis reflected a block in stable
RNA synthesis and this effect is not mediated by ppGpp [28].
Yops accumulate in the membrane fraction after 3 h of induction,
whereas transcription of the yop genes during Ca
2+-deficiency is
dramatically reduced [57]. Our results showed that the DrelA
DspoT mutations did not affect yop transcription, but resulted in
reduced synthesis and secretion of LcrV and a number of Yops,
including YopD. YopD is essential for several discrete steps during
efficient Yop effector translocation [58], therefore, the reduction of
YopD synthesis might directly impair the secretion of other Yops.
A number of studies report the involvement of ppGpp in
processes related to growth, stress, starvation, and survival that
affect pathogenicity. A frequent scenario is that in relA spoT
mutants, pathogenicity is compromised for reasons that vary with
the organism studied and include pathogen/host interactions,
invasiveness and persistence [59]. Our observations indicate that
the relA-dependent accumulation of ppGpp does not play a major
role in Y. pestis pathogenicity. The DrelA Y. pestis mutant was as
virulent as wild type Y. pestis KIM5
+ (Fig. 6), while the DrelA DspoT
Y. pestis mutant was dramatically attenuated. The growth defect
observed in vitro for the DrelA DspoT strain may have contributed
to this reduction in virulence. Zusman et al showed that an L.
pneumophila relA mutant is capable of wild-type intracellular
proliferation in both human macrophage and the protozoan host
Acanthamoeba castellanii [15]. A S. Typhimurium DrelA mutant also
showed no significant differences in invasion, intracellular growth,
virulence, or expression of a number of SPI-1 genes [18]. Unlike S.
Typhimurium, wild-type Y. pestis and L. pneumophila are not
capable of growth on defined medium unless supplemented with
amino acids that also serve as a carbon source for these pathogens
[60,61,62]. The pattern of amino acid requirements of Y. pestis is
similar to that of the Legionella [60] and S. Typhimurium DrelA
DspoT strains [63], including two branched chain amino acids,
phenylalanine and threonine. But amino acid auxotrophs designed
to duplicate the amino acid requirements of DrelA DspoT mutants
do not affect intracellular growth and virulence of Legionella [64,65]
Table 3. Differentially expressed proteins identified from Y. pestis at 37uC.
Protein
number Protein name Accession No. Function Method Fold change
WT/DrelADspoT
1 LcrH (SycD) secretion chaperone YPCD1.30c chaperone for YopBD MALDI 2.3
2 FrsA (fermentation/respiration switch protein) y0964 FrsA may promote fermentation MALDI 2.8
3 MetK (S-adenosylmethionine synthetase) y3314 catalyzes the formation of S-adenosylmethionine from
methionine and ATP; methionine adenosyltransferase
MALDI 4.2
4 CodA (cytosine deaminase) y3946 salvage of nucleosides and nucleotides MALDI 1.5
5 Pla (outer membrane protease) YPPCP1.07 outer membrane protease; involved in virulence in many
organisms
MALDI 2.6
6,7,8 LcrV (secreted effector protein) YPCD1.31c functions in needle complex protein export; Yop
secretion and targeting control protein; important
for translocation pore formation
MALDI 7.3
9 TrpA (tryptophan synthase subunit alpha) y2047 amino acid biosynthesis: Tryptophan MALDI 1.6
10 TyrS (tyrosyl-tRNA synthetase) y1966 aminoacyl tRNA synthetases, tRNA modification MALDI 1.6
11 hypothetical protein y2786 putative membrane protein MALDI 2.3
12 Kbl (2-amino-3-ketobutyrate coenzyme A
ligase)




Figure 5. Survival of Swiss Webster mice (3 mice per strain)
infected s.c. with Y. pestis KIM5
+ (black circles),
x10003(pCD1Ap) (black squares), x10004(pCD1Ap) (black
triangles) and x10019(pCD1Ap) cultured with 0.05% arabinose
in vitro (black diamonds). The experiment was performed twice with
similar results.
doi:10.1371/journal.pone.0006720.g005
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+ (black) or x10004(pCD1Ap) (white) in mouse tissues. Groups of nine mice were
inoculated s.c., and at various times CFU per organ in the blood (A), lungs (B), spleens (C) and livers (D) were determined for 3 mice per group. Error
bars represent standard deviation.
doi:10.1371/journal.pone.0006720.g006
Figure7. Antibody responsein sera ofmice inoculated with Y. pestisKIM5
+ orx10004(pCD1Ap). A Y. pestis whole cell lysatewasused as the
coating antigen. (A) Serum IgG responses. (B) Serum IgG1 and IgG2a responses. *, the P value was less than 0.01; **, the P value was less than 0.05.
doi:10.1371/journal.pone.0006720.g007
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(SpoT-dependent) ppGpp levels that affect pathogenicity of Y.
pestis and not the stringent response induced by amino acid
starvation.
The increased LD50 and lung colonization deficiency of the
ppGpp null mutant indicates that ppGpp may regulate genes
important in establishing a lethal infection during bubonic plague.
Only a modest degree of attenuation was observed in the
pneumonic model (unpublished data). The pneumonic model
bypasses the need to reach the lungs, indicating that it is the ability
to reach the lungs, and not the ability to colonize the lungs, per se,
that is at least partially responsible for the attenuation phenotype.
This suggests that relA and spoT are required for expression of
genes that facilitate lung invasion after subcutaneous entry into the
host. Furthermore, this observation highlights the point that
mutant strains are not universally attenuated for virulence, and
route of infection is an important consideration when investigating
the phenotype of a mutant.
Results of proteome analysis indicated that the absence of
ppGpp in Y. pestis reduced Pla and LcrH synthesis at 37uC
(Table 3). This may be another important factor leading to
attenuation. Pla is a member of the omptin surface protease family
and cleaves host plasminogen and components of the complement
pathway [66]. Independent of this protease activity, Pla binds to
the extracellular matrix component laminin and promotes
invasion of endothelial cells [67]. Inactivation of pla severely
attenuates Y. pestis during bubonic infection [68,69]; however, a pla
mutant is still lethal during intranasal or intravascular infection
[70]. In addition, the YopE and YopH type III effector proteins
disrupt the host cell cytoskeleton allowing the bacterium to resist
phagocytosis [71,72] and are required for Y. pestis virulence
[20,73]. Therefore, the reduction in YopE and YopH synthesis
observed in the DrelA DspoT mutant may also contribute to
attenuation.
High titers of anti-Y. pestis serum IgG were produced by
vaccination with the DrelA DspoT Y. pestis mutant and antibody-
based humoral immunity provides good protection against
bubonic plague [74,75]. Although a mixed Th1/Th2-type
immune response was initially induced by this attenuated strain,
the response became slightly biased to a Th2-type humoral
immune response. Y. pestis secretes LcrV and Yops during
infection. LcrV triggers the release of IL-10 by host immune cells
and suppresses proinflammatory cytokines such as TNF-a and
INF-c as well as innate defense mechanisms required to combat
the pathogenesis of plague [76,77]. Our results were similar to
previous findings. We were unable to detect TNF-a and IFN-c in
sera of mice inoculated with the wild-type or the ppGpp null
mutant, but the IL-10 levels induced by the ppGpp null mutant
were significantly lower than that of wild type strain (Fig. 7). The
reduction in LcrV expression in the ppGpp null mutant could be
responsible for the decrease in IL-10 production. However, the
reduced expression of LcrV and Yops was not sufficient to permit
induction of the proinflammatory cytokines TNF-a and IFN-c.
Subcutaneous immunization with DrelA DspoT strain
x10004(pCD1Ap) protected mice against s.c. challenge (simulating
bubonic plague) and i.n. challenge (simulating pneumonic plague),
but protection against i.n. challenge was not complete (Fig. 8) in
spite of high serum titers of anti-Y. pestis IgG (Fig. 7). This result is
consistent with what is known about the immunogenicity
requirements for protection against Y. pestis. Protection against
Figure 8. Mouse survival after Y. pestis KIM5
+ Challenge. (A) Swiss Webster mice vaccinated s.c. with 2.5610
4 CFU of x10004(pCD1Ap) and a
were challenged with 1.5610
5 CFU of Y. pestis KIM5
+ via the s.c. route. (B) Swiss Webster mice vaccinated s.c. with 2.5610
4 CFU of x10004(pCD1Ap)
were challenged via the i.n. route with 2610
4 CFU of Y. pestis KIM5
+. Immunization provided significant protection against both challenge routes
(P,0.001). For each experiment, there were 10 mice in the vaccinated group and 4 mice in the control group.
doi:10.1371/journal.pone.0006720.g008
Figure 9. IL-10 production in sera of mice inoculated with Y.
pestis KIM5
+ or x10004(pCD1Ap). *, the P value was less than 0.01;
**, the P value was less than 0.05.
doi:10.1371/journal.pone.0006720.g009
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protection against pneumonic plague may require cell mediated
immunity induced by INF-c and TNF-a [78,79]. This view is
supported by vaccine trials with nonhuman primates indicating
that humoral immunity may not protect humans against
pulmonary Y. pestis infection. Specifically, studies by researchers
at the USAMRIID found that a significant number of nonhuman
primates immunized with the F1-V fusion protein vaccine
succumbed to aerosol Y. pestis challenge, despite high-titer serum
antibodies against F1-V at the time of challenge [80,81,82].
Therefore, antibodies alone are not sufficient to protect against
pneumonic plague. Recent studies demonstrated that cytokine-
mediated immunity could augment protection against lethal
pulmonary Y. pestis challenge in the presence or absence of
specific antibody [79,83]. Therefore, absence of TNF-a and IFN-c
in sera may be the major reason we observed poor protection
efficacy against pneumonic plague.
Based on these results, an effective plague vaccine needs to
prime not only humoral immunity but also strong Th1-type
cellular immunity [79,84]. To induce effective cellular immunity
we will further modify our DrelA DspoT strain to permit induction
of cellular immune responses.
Supporting Information
Table S1 Primers
Found at: doi:10.1371/journal.pone.0006720.s001 (0.07 MB
DOC)
Figure S1 Schematic chromosome structure of Y. pestis KIM6+,
x10021 (spoT412:: 36flag-kan), x10019 (DrelA233 DspoT85
DlacZ516::TT araC PBAD spoT) and x10022 (DrelA233 DspoT85
DlacZ516 VTT araC PBAD spoT413:: 36flag-kan).
Found at: doi:10.1371/journal.pone.0006720.s002 (0.23 MB TIF)
Figure S2 Measurement of SpoT expression M, protein marker;
1, Y. pestis KIM6+;2 ,x10021; 3, x10022 (without arabinose); 4,
x10022 (with 0.05% arabinose); 5, x10022 (with 0.1% arabinose);
6, x10022 (with 0.15% arabinose); 7, x10022 (with 0.2%
arabinose); 8, x10022 (with 0.3% arabinose).
Found at: doi:10.1371/journal.pone.0006720.s003 (0.90 MB TIF)
Figure S3 2-DE gels showing differential protein expression A.
Comparing differential protein expression between KIM5+(wild-type
Y. pestis)a n dx10004-pCD1Ap (DrelA233 DspoT85)a t2 6 uC. B.
Comparing differential protein expression between KIM5+(wild-type
Y. pestis)a n dx10004-pCD1Ap (DrelA233 DspoT85)a t3 7 uC.
Found at: doi:10.1371/journal.pone.0006720.s004 (1.16 MB TIF)
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